For an adult with iron deficiency (ferritin 13 ng/mL), is ferrous sulfate 325 mg taken every other day more effective than daily dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternate-Day Ferrous Sulfate 325 mg Is Superior to Daily Dosing for Iron Deficiency

For an adult with iron deficiency (ferritin 13 ng/mL), ferrous sulfate 325 mg taken every other day is the preferred regimen because it increases fractional iron absorption, reduces gastrointestinal side effects, and achieves similar hemoglobin and ferritin improvements compared to daily dosing. 1

Physiological Rationale for Alternate-Day Dosing

  • When you take oral iron, serum hepcidin rises within hours and remains elevated for 24–48 hours, blocking iron absorption from subsequent doses taken the same day or the next day. 1
  • A single dose ≥60 mg elemental iron (which 325 mg ferrous sulfate provides, containing ~65 mg elemental iron) triggers this hepcidin surge, reducing absorption of a second dose by 35–45%. 1, 2
  • Alternate-day dosing allows hepcidin to fall between doses, significantly increasing fractional iron absorption compared to consecutive daily dosing. 1, 3

Evidence Comparing Daily vs. Alternate-Day Dosing

Absorption and Efficacy

  • In iron-depleted women, alternate-day dosing produced 21.8% fractional iron absorption versus 16.3% with consecutive daily dosing (p=0.0013), and cumulative total iron absorption was 175.3 mg versus 131.0 mg over the same treatment period (p=0.0010). 3
  • At equal total iron doses over 6 months, alternate-day dosing achieved median serum ferritin of 44.8 μg/L versus 43.8 μg/L with daily dosing (no significant difference), but iron deficiency prevalence at 6 months was lower with alternate-day dosing (3.0% vs. 11.4%, p=0.049). 4
  • In premenopausal women with IDA, both daily and alternate-day single-dose regimens produced similar hemoglobin increases at 3 months (no significant difference between groups). 5, 6

Side Effects

  • Gastrointestinal side effects occur 56% more frequently with consecutive daily dosing compared to alternate-day dosing (longitudinal prevalence ratio 1.56,95% CI 1.38–1.77, p<0.0001). 4
  • In a cohort study, GI side effects occurred in only 3.3% of patients on alternate-day single doses versus 10% on daily single doses and 43.3% on daily double doses. 6
  • Daily dosing was associated with significantly more GI complaints than alternate-day dosing in multiple studies. 5, 6

Recommended Dosing Algorithm

First-Line Regimen

  • Prescribe ferrous sulfate 325 mg (providing ~65 mg elemental iron) every other day in the morning on an empty stomach. 1, 2
  • This regimen optimizes absorption, minimizes side effects, and achieves iron repletion comparable to daily dosing. 1, 3, 4

If Alternate-Day Dosing Is Not Tolerated

  • Take the same dose with 250–500 mg vitamin C to enhance absorption. 1
  • Take with a small amount of food if empty-stomach dosing causes intolerable nausea, though this reduces absorption. 1

Avoid These Common Errors

  • Do not prescribe twice-daily dosing (e.g., 325 mg twice daily), as the second dose will be poorly absorbed due to hepcidin elevation and will cause significantly more GI side effects without improving outcomes. 1, 2, 5, 6
  • Do not take iron with coffee, tea, or calcium-containing foods/supplements within 1–2 hours, as these inhibit absorption. 1, 2
  • Do not use modified-release or enteric-coated preparations, which release iron beyond the duodenum and are poorly absorbed. 1, 2

Monitoring Treatment Response

Week 2 Checkpoint

  • Check hemoglobin at 2 weeks; an increase ≥10 g/L (≥1 g/dL) predicts treatment success with 90% sensitivity and 79% specificity. 1, 2, 5
  • Failure to achieve this rise suggests non-adherence, ongoing blood loss, malabsorption, or concurrent B12/folate deficiency and warrants investigation. 1, 2

Month 3–6 Follow-Up

  • Recheck complete blood count and ferritin at 3 months. 1, 2
  • Continue iron for approximately 3 months after hemoglobin normalizes to fully replenish bone marrow iron stores. 1, 2
  • Monitor hemoglobin every 6 months during the first year to detect recurrence. 2

When to Switch to Intravenous Iron

  • No hemoglobin rise after 2–4 weeks of adherent oral therapy (early oral non-responders have only 21% chance of later response with continued oral iron versus 65% with IV iron). 2
  • Intolerable GI side effects despite alternate-day dosing and other modifications. 1, 2
  • Malabsorption syndromes (inflammatory bowel disease, celiac disease, post-bariatric surgery). 1, 2
  • Ongoing blood loss exceeding oral replacement capacity. 2

Key Clinical Pearls

  • Alternate-day dosing is not "slower" therapy—it achieves similar or better iron repletion at equal total doses because of superior fractional absorption. 3, 4
  • The hepcidin-mediated absorption block is the reason why "more frequent" does not mean "more effective" with oral iron. 1, 3
  • For your patient with ferritin 13 ng/mL, prescribe ferrous sulfate 325 mg every other day rather than daily to maximize both efficacy and tolerability. 1, 3, 4

Related Questions

In a healthy woman at 14 weeks gestation with a hemoglobin of 9.4 g/dL, what is the appropriate management?
What supplements or treatments are recommended for an 18-year-old female with iron deficiency (low iron saturation of 13%) and symptoms of fatigue and depression?
What is the duration and monitoring frequency for ferrous fumarate (iron supplement) syrup treatment in a 2-year-old child with anemia?
What is the treatment for a 2-year-old male with iron deficiency anemia, hypochromia, microcytosis, and evidence of hemolysis?
In a 14‑week pregnant woman with isolated hemoglobin of 9.4 g/dL and otherwise normal findings, what is the appropriate management?
In an acute ischemic stroke patient who cannot receive intravenous alteplase, what is the next‑most appropriate acute treatment?
What is the recommended method to safely correct hypernatremia in a patient with subarachnoid hemorrhage?
In a patient with gas trapping and hyperinflation on pulmonary function testing, what is the likely diagnosis, differential diagnosis, and initial management?
For a child with influenza B, after how many days from symptom onset can they return to school, assuming they have been afebrile for at least 24 hours without antipyretics?
What is the appropriate starting dose of gabapentin (Neurontin) for a patient with an estimated glomerular filtration rate of about 50 mL/min?
Is hypertonic sodium‑lactate (Totilac) useful for acute ischemic stroke patients with large infarcts and malignant cerebral edema causing refractory intracranial hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.